Tayo Sanders II, Ph.D.

Venture Studio Director


Tayo Sanders II, Ph.D., has spent the last seven years working with investors and startups in the biotech and industrial technology space. Most recently, he led due diligence on more than 15 companies, totaling more than $130 million in deployed capital as a senior member of the investment team at the Boston-based VC firm, Anzu Partners. Prior to that, Tayo led technical diligence on Anzu’s first investment, Axsun Technologies, which was acquired for an 8x return in 2019. Tayo received a Ph.D. in Biomedical Engineering at the University of Oxford as a Rhodes Scholar, and a Bachelor of Science in Materials Science from the University of Wisconsin-Eau Claire.

Related Articles

Southern Research launches Venture Studio

November 22, 2022

Southern Research has launched a Venture Studio to develop startups that will bring new therapeutic products to market. In conjunction with its partners, Southern Research has more than 20 drug programs currently in preclinical development. These programs hold enormous potential for patients in t...
Read More

Southern Research and Rhodium Scientific send bacteria to space to explore potential cancer treatments

November 7, 2022

Southern Research and Rhodium Scientific have partnered to send bacteria to space on a mission to find new hope for people with cancer. When Northrop Grumman’s Antares rocket launched ...
Read More

Moving Science in the next 80 years

September 29, 2022

Since our founding in Birmingham more than 80 years ago, Southern Research has played a pivotal role in Birmingham’s economy and in the scientific advances that have transformed our world. In the past year, we’ve updated our logo and refreshed our website, but we are still doing today what we’...
Read More